Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental and care coordination solutions. Further, it provides tech-enabled services, such as implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third-party administrator services; and complementary hardware and devices for third parties. The company serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.
IPO Year: 1986
Exchange: NASDAQ
Website: cerner.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/11/2022 | Buy → Hold | Argus | |
| 12/22/2021 | Overweight → Sector Weight | Keybanc | |
| 12/21/2021 | $85.00 → $95.00 | Equal-Weight | Morgan Stanley |
| 12/21/2021 | $86.00 → $95.00 | Outperform → Sector Perform | RBC Capital |
| 12/21/2021 | $88.00 → $95.00 | Outperform → Market Perform | SVB Leerink |
| 12/20/2021 | $77.00 → $85.00 | Underweight → Equal-Weight | Morgan Stanley |
| 11/17/2021 | $82.00 | Neutral | Robert W. Baird |
| 11/17/2021 | $82.00 | Neutral | Baird |
| 11/1/2021 | $77.00 → $79.00 | Equal-Weight | Barclays |
| 8/31/2021 | $70.00 → $75.00 | Underweight | Morgan Stanley |
Argus downgraded Cerner from Buy to Hold
Keybanc downgraded Cerner from Overweight to Sector Weight
Morgan Stanley reiterated coverage of Cerner with a rating of Equal-Weight and set a new price target of $95.00 from $85.00 previously
RBC Capital downgraded Cerner from Outperform to Sector Perform and set a new price target of $95.00 from $86.00 previously
SVB Leerink downgraded Cerner from Outperform to Market Perform and set a new price target of $95.00 from $88.00 previously
Morgan Stanley upgraded Cerner from Underweight to Equal-Weight and set a new price target of $85.00 from $77.00 previously
Robert W. Baird initiated coverage of Cerner with a rating of Neutral and set a new price target of $82.00
Baird initiated coverage of Cerner with a rating of Neutral and set a new price target of $82.00
Barclays reiterated coverage of Cerner with a rating of Equal-Weight and set a new price target of $79.00 from $77.00 previously
Morgan Stanley reiterated coverage of Cerner with a rating of Underweight and set a new price target of $75.00 from $70.00 previously
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the
Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market. "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longs
CALGARY, AB, Jan. 25, 2022 /CNW/ - Comprehensive Healthcare Systems Inc. (TSXV:CHS) (the "Company" or "CHS"), an industry leader in Healthcare Benefits Administration software and services, is pleased to announce the appointment of Chris Cosgrove as the Company's new President and Chief Executive Officer ("CEO") and to its board of directors effective February 1, 2022. Mr. Cosgrove has 25 years of management and leadership experience in the healthcare technology industry and will replace CHS founder, Dr. Hassan Mohaideen, who will continue in his role as Chairman of the board of directors (the "Board") and be appointed Chief Medical Officer of the Company. "With a proven track record of lea
Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Major General Elder Granger, M.D., U.S. Army (retired) to its board of directors. "Dr. Granger's track record of leadership in navigating complex policy, regulatory and competitive environments will be welcome additions to the Better Therapeutics board," said David Perry, co-founder and chairman of Better Therapeutics. "His extensive board experience coupled with an unwavering commitment to improving the delivery of healthcare will be invaluable as we wo
Highly Accomplished Visionary with Proven Track Record of Leading Healthcare Businesses Cerner Board Separates Chairman and CEO Roles and Names William Zollars Chairman of Board of Directors KANSAS CITY, Mo., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN) today announced that its Board of Directors has appointed David Feinberg, M.D., MBA, as President and Chief Executive Officer, effective October 1, 2021. He succeeds Brent Shafer, who previously announced his decision to transition from chairman and CEO. Dr. Feinberg will serve as a member of the Board of Directors. Cerner's current President, Donald Trigg, will leave Cerner. Cerner's Board of Directors also announ